Veterinary Cytology

Criteria of malignancy in veterinary cytology

Veterinary clinical pathologists assess a set of well-established, widely taught cytologic criteria of malignancy when interpreting a sample — no single criterion is diagnostic on its own, and a cytologic diagnosis is a probability assessment based on the combined pattern, not a single feature. The criteria commonly evaluated include:

• Nuclear-to-cytoplasmic (N:C) ratio — an increased, variable N:C ratio across a cell population.
• Anisokaryosis and anisocytosis — variation in nuclear size and overall cell size beyond what is expected for the tissue of origin.
• Nuclear molding and multinucleation — nuclei that deform against one another, or cells with multiple, unevenly sized nuclei.
• Coarse or abnormally clumped chromatin — chromatin pattern that departs from the fine, even pattern typical of well-differentiated cells.
• Nucleolar changes — multiple nucleoli, variably sized nucleoli, or macronucleoli within a single cell or across the population (anisonucleoliosis).
• Mitotic activity — an increased number of mitotic figures and, more specifically, atypical or bizarre mitotic figures.
• High cellularity and loss of normal cell cohesion — exfoliation of unusually large numbers of cells, or cells that have lost the normal architectural cohesion expected of that tissue.

Because these are pattern-based, probabilistic criteria rather than a checklist that yields a certain answer, a cytologic report will typically frame a result as consistent with, suspicious for, or inconclusive for malignancy, and equivocal or borderline samples are commonly escalated to histopathology (which preserves tissue architecture) for a definitive diagnosis. Procurement and lab-workflow implications follow directly from this: a lab or practice buying cytology capability or a reference-lab contract should confirm that ambiguous cases have a documented escalation pathway to histopathology, and that the interpreting pathologist’s report distinguishes a definitive diagnosis from a descriptive or suspicious finding rather than overstating certainty either way.

What to evaluate when procuring veterinary cytology capability or services

A veterinary practice, diagnostic laboratory, or research-animal facility making a cytology-related purchasing decision — whether that means building in-house capability, contracting a reference laboratory, or adding a digital/telecytology option — should evaluate:

• Pathologist credentials — whether definitive interpretations, especially malignancy calls, are read by a board-certified veterinary clinical pathologist (ACVP-Clinical Pathology diplomate) rather than only a general practitioner or unsupervised technician; ask any reference lab or telecytology vendor directly which credential level reads which tier of case.
• Laboratory accreditation — whether the diagnostic laboratory holds a recognized accreditation such as American Association of Veterinary Laboratory Diagnosticians (AAVLD) accreditation, or operates under an ISO 15189 or ISO/IEC 17025-aligned quality system; accreditation status is independently verifiable and should not be taken on a vendor’s marketing claim alone.
• Turnaround time (TAT) — published, contractually stated TAT for routine versus stat/urgent cases, and how TAT is affected by courier schedule for practices without on-site drop-off.
• Sample-quality feedback and rejection criteria — whether the lab documents and reports back on non-diagnostic or low-cellularity samples, since sample quality (collection technique, smear preparation, staining consistency, and drying artifact) is the single largest controllable driver of a usable cytology result; this has direct staff-training and consumables-procurement implications (slide type, stain quality, fixative choice).
• In-house versus reference-lab split — which case types are appropriate to interpret in-house (e.g., routine ear or skin cytology, fluid cell counts) versus which should be routed to a board-certified pathologist (masses with malignancy concern, cases with legal or insurance significance, diagnostically ambiguous patterns); see our digital pathology scanner buying guide for the related decision of whether to digitize slides for remote/telecytology review rather than shipping physical glass.
• Equipment and consumables — microscope quality and service (see our microscope service contract guide for what to negotiate), stain quality and shelf life, and calibration/maintenance history where applicable (see accredited calibration services).
• System integration — whether the reference lab’s reporting integrates with the practice or facility’s practice-information system (PIMS) or laboratory information system; see our LIMS vs. LIS comparison for the underlying distinction between inventory/workflow systems and clinical reporting systems that a cytology report needs to flow into.
• Cost structure and total cost of ownership — per-case reference-lab fees versus the fully loaded cost of in-house capability (microscope, stains, consumables, staff time, and the opportunity cost of interpreting ambiguous cases without board-certified backup).

Some diagnostic-laboratory supply distributors — for example LAC Health, a laboratory and diagnostic-supply distributor — supply cytology stains, slides, and related consumables alongside broader lab-supply catalogs; a distributor relationship is one procurement channel among several and should be evaluated on the same documented criteria (product quality, lot consistency, service reliability) as any other supplier, not treated as a substitute for verifying pathologist credentials or laboratory accreditation directly.

Veterinary cytology continuing education (CE)

Because cytologic interpretation is a pattern-recognition skill that depends heavily on ongoing case exposure, continuing education is a real, recurring line item for practices and labs maintaining in-house cytology capability, not just an individual credentialing formality. Relevant CE considerations for a lab manager or practice owner budgeting for staff development include:

• RACE approval — in the United States, veterinary CE hours that count toward state licensure renewal generally need to be approved by the American Association of Veterinary State Boards’ Registry of Approved Continuing Education (RACE); confirm any cytology CE course’s RACE-approval status and which state boards accept it before budgeting staff time against it.
• Professional-society resources — the American Society for Veterinary Clinical Pathology (ASVCP) is the principal U.S. professional body for veterinary clinical pathology and publishes case-based educational material and quality-assurance guidance relevant to cytology practice; its resources are a reasonable starting point when evaluating whether a CE program’s content is current with accepted diagnostic criteria.
• Format — cytology CE is commonly delivered as case-review webinars, slide-based workshops, or vendor-run education (some reference laboratories and diagnostic distributors offer CE as part of an existing service relationship); evaluate format against how the skill is actually used — case-pattern recognition benefits from image-heavy, case-based formats more than lecture-only formats.
• Who needs it — both veterinarians performing first-pass in-house interpretation and veterinary technicians responsible for sample collection and slide preparation benefit from targeted CE, since preparation quality is as large a driver of diagnostic yield as interpretation skill.

When evaluating a CE vendor or course as a purchasing decision, ask for the RACE approval number and expiration, confirm it against your practice’s state licensing board requirements directly rather than relying on the vendor’s claim alone, and check whether the course content reflects current, board-certified-pathologist-reviewed diagnostic criteria rather than dated material.

Where to go for a fuller veterinary cytology reference

This page is written for the procurement and lab-management decisions around veterinary cytology capability — credentials, accreditation, workflow, and CE — rather than as a step-by-step interpretation manual. For actual slide-by-slide interpretation guidance, veterinary clinical pathology training programs, ACVP-affiliated resources, and established veterinary cytology and hematology reference texts are the appropriate next step; a practice building in-house capability should budget for one of these as a standing reference alongside, not instead of, access to board-certified pathologist consultation for ambiguous cases.

Frequently asked questions

What are the criteria of malignancy used in veterinary cytology?

Commonly assessed criteria include an increased and variable nuclear-to-cytoplasmic ratio, anisokaryosis and anisocytosis, nuclear molding, coarse or clumped chromatin, multiple or irregular nucleoli, increased or atypical mitotic figures, and high cellularity with loss of normal cell cohesion. These are evaluated together as a pattern, not individually, and a cytologic result is typically reported as consistent with, suspicious for, or inconclusive for malignancy rather than an absolute diagnosis.

Is veterinary cytology CE required for licensure?

General continuing education is required for veterinary license renewal in most U.S. states, and hours generally need RACE approval (via the AAVSB Registry of Approved Continuing Education) to count; whether cytology-specific CE is separately required depends on the state board and, for credentialed technicians, the relevant credentialing body — confirm directly with your state veterinary board rather than assuming a course’s marketing claim of “CE credit” satisfies your specific jurisdiction’s requirement.

Should a practice interpret cytology in-house or send it to a reference lab?

Most practices do both: straightforward, low-risk samples (routine ear or skin cytology, basic fluid cell counts) are commonly read in-house, while masses with malignancy concern, diagnostically ambiguous patterns, or cases with legal/insurance significance are typically referred to a board-certified veterinary clinical pathologist. The right split depends on in-house staff training, case volume, and how much diagnostic risk the practice is willing to carry without board-certified backup.

What is the difference between veterinary cytology and histopathology?

Cytology examines individual, disaggregated or exfoliated cells and is faster and less invasive to collect (fine-needle aspiration, impression smear, fluid sampling); histopathology examines intact tissue architecture from a biopsy or excised sample and generally provides a more definitive diagnosis, particularly for equivocal cytology results, because architecture (not just individual cell features) is diagnostic for many tumor types.